The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

OA affects about 15-20% of the Indian population, especially the elderly, with women being more vulnerable. It leads to joint ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

Alembic Pharmaceuticals partners with Amlan International to bring innovative poultry health solutions to India's market.

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

CCI investigates cartel cases in health and pharma sector, signs global agreements, introduces new mechanisms to combat ...

The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Many firms that participated in the program failed to kickstart production, while others that met manufacturing targets found ...